Skip to main content

Day: February 19, 2021

Arbor Realty Trust Reports Fourth Quarter and Full Year 2020 Results and Increases Dividend for Third Consecutive Quarter to $0.33 per Share

Fourth Quarter Highlights:Diversified operating platform with a multifamily focus that continues to produce strong distributable earnings and dividends in all cyclesGAAP net income of $0.80 and distributable earnings of $0.49 per diluted common share1Raised cash dividend on common stock to $0.33 per share, our third consecutive quarterly increaseContinued strong performance from our residential mortgage banking joint venture generating pretax income of $19.6 millionRaised $105 million of accretive growth capital through the issuance of common sharesAgency Business:Segment income of $70.9 millionRecord loan originations of $2.75 billion, an 87% increase over last quarterServicing portfolio of $24.63 billion representing 9% growth in the current quarterStructured Business:Segment income of $39.9 millionPortfolio growth of 7% on $985.2 million...

Continue reading

Capital Power reports fourth quarter and year-end 2020 results

EDMONTON, Alberta, Feb. 19, 2021 (GLOBE NEWSWIRE) — Capital Power Corporation (TSX: CPX) today released financial results for the quarter ended December 31, 2020.HighlightsGenerated net cash flows from operating activities of $159 million and adjusted funds from operations (AFFO) of $86 million in the fourth quarter of 2020Generated net income of $1 million and adjusted EBITDA of $220 million in the fourth quarter of 2020Announced decision to be off coal in 2023Full notice to proceed on the repowering of Genesee 1 and 2 that will add 560 megawatts when repowering is completed in 2023 and 2024Executed 20-year contracts for three new solar development projects in North CarolinaExecuted a 25-year power purchase agreement for Strathmore Solar project in AlbertaProceeding with the Enchant Solar project in Alberta with commercial operations...

Continue reading

SHELL MIDSTREAM PARTNERS, L.P. 4th QUARTER 2020 UNAUDITED RESULTS

Houston, Feb. 19, 2021 (GLOBE NEWSWIRE) — Shell Midstream Partners, L.P. (NYSE: SHLX) (the “Partnership” or “Shell Midstream Partners”) reported net income attributable to the Partnership of $129 million for the fourth quarter of 2020, which equated to $0.29 per diluted common limited partner unit. Shell Midstream Partners also generated adjusted earnings before interest, income taxes, depreciation and amortization attributable to the Partnership of $188 million.Total cash available for distribution was $162 million, approximately $1 million lower than the prior quarter. The Partnership was impacted by late season storms in the Gulf of Mexico, planned turnaround activities and the continuing effects of the COVID-19 pandemic. However, these headwinds were largely offset by increased throughput on the Zydeco system, as well as on certain...

Continue reading

Mersana Therapeutics to Host Conference Call Announcing Fourth Quarter and Year End 2020 Financial Results and Business Updates

CAMBRIDGE, Mass., Feb. 19, 2021 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced that it will host a conference call and webcast on Friday, February 26, 2021 at 8:00 a.m. ET to report financial results for the fourth quarter and year ended December 31, 2020 and provide business updates.To access the call, please dial 877-303-9226 (domestic) or 409-981-0870 (international) and provide the Conference ID 2354447. A live webcast of the presentation will be available on the Investors & Media section of the Mersana website at www.mersana.com.About Mersana TherapeuticsMersana Therapeutics is a clinical-stage biopharmaceutical...

Continue reading

Patriot Bank Announces Significant Upgrade to SBA Team

STAMFORD, Conn., Feb. 19, 2021 (GLOBE NEWSWIRE) — Patriot National Bancorp, Inc. (“Patriot”) (NASDAQ:PNBK), the parent company of Patriot Bank, N.A. (the “Bank”), today announced the reorganization of the SBA team to strengthen its nationwide SBA Business Lending Unit platform. The Bank believes this will assist more Small Businesses in obtaining needed capital.Mr. Gary Griffin has been hired as the National SBA Sales Manager. Mr. Griffin brings over 30 years of extensive SBA and leadership experience. Mr. Griffin holds degrees in Finance from University of Denver and Accounting from Georgia State University.Mr. Michael Green to serve as Vice President, Business Development Officer working out of Georgia. Mr. Green brings over 25 years of experience in the SBA industry. Mr. Green holds a degree in Accounting from Howard University.Mr....

Continue reading

Intercept to Present at Upcoming Investor Conferences

NEW YORK, Feb. 19, 2021 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that Jerry Durso, President and Chief Executive Officer, and Sandip Kapadia, Chief Financial Officer of Intercept, will present at the SVB Leerink 10th Annual Global Healthcare Conference on Friday, February 26, 2021 at 1:00 p.m. ET, and at the Cowen 41st Annual Healthcare Conference on Tuesday, March 2, 2021 at 10:30 a.m. ET.A live webcast of the events will be available on the investor page of Intercept’s website at http://ir.interceptpharma.com. An audio archive of the webcast will also be available on Intercept’s website for approximately two weeks.About InterceptIntercept is a...

Continue reading

Crawford & Company® Announces Fourth Quarter 2020 Earnings Conference Call

ATLANTA, Feb. 19, 2021 (GLOBE NEWSWIRE) — Crawford & Company® (NYSE: CRD-A and CRD-B), the world’s largest publicly listed independent provider of claims management and outsourcing solutions to carriers, brokers and corporations, will issue its earnings release for its fourth quarter ended December 31, 2020, on Thursday, March 4, 2021, at 4:15 p.m., Eastern time.The quarterly conference call, to discuss Crawford®’s quarterly earnings and other developments, will be held on Friday, March 5, 2021, at 8:30 a.m. Eastern time.For audio access only, the call can be accessed by dialing 1-833-968-1973, Conference ID: 1388329. For audio and slide presentation access, the call is being webcast by Q4 Inc, https://event.on24.com/wcc/r/2929611/098C62D1FAECAF3CC6785675465E16CE; the call can be accessed on the Crawford & Company investor...

Continue reading

Major Drilling to Release Third Quarter Results for Fiscal 2021

MONCTON, New Brunswick, Feb. 19, 2021 (GLOBE NEWSWIRE) — Major Drilling Group International Inc. (TSX: MDI) (the “Company”) today reported that it will release its third quarter results, ended January 31, 2021, on Thursday, March 4, 2021 after the markets have closed.Webcast/Conference Call DetailsDenis Larocque, President & Chief Executive Officer, and Ian Ross, Chief Financial Officer, invite you to participate in a webcast/conference call on Friday, March 5, 2021 at 9:00 a.m. Eastern to discuss the Company’s third quarter results for fiscal 2021.To access the webcast, which includes a slide presentation, please go to the investors/webcasts section of the Major Drilling website at www.majordrilling.com and click on the link. Please note that this is listen-only mode.To participate in the conference call please dial 416-340-2217,...

Continue reading

Vaccinex Announces Signing of Two Multi-Project Deals with Leading Pharmaceutical Companies Focused on Leveraging Its ActivMAb® Platform

ROCHESTER, N.Y., Feb. 19, 2021 (GLOBE NEWSWIRE) — Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating cancer and neurodegenerative disease through the inhibition of SEMA4D, today announced the signing of multi-project deals with two undisclosed prominent pharmaceutical companies. The collaborations will focus on using ActivMAb®, Vaccinex’s antibody discovery and novel viral display platform, for antibody discovery against complex antigens such as GPCRs and ion channels. Financial terms of the deals are undisclosed.“Our ActivMAb platform has delivered numerous promising antibody-based solutions for complex therapeutic targets, both for our own R&D efforts and those of our partners,” said Ernest Smith, chief scientific officer of Vaccinex. “These two collaboration...

Continue reading

Phase Change Materials Market Size to Reach USD 4,174.8 Million by 2027; Increasing Adoption of PCMs in Building Materials to Stimulate Growth, Says Fortune Business Insights™

Pune, India, Feb. 19, 2021 (GLOBE NEWSWIRE) — The global phase change materials market size is expected to experience significant growth by reaching USD 4,174.8 million by 2027. This is attributable to the increasing adoption of phase change materials in manufacturing building materials and the stringent imposition of environmental laws to reduce greenhouse gases emissions globally. Fortune Business Insights, in its latest report, titled, “Phase Change Materials Market Size, Share & COVID-19 Impact Analysis, By Type (Organic, Inorganic, & Eutectic), By Application (Building & Construction, HVAC, Thermal Energy Storage, Cold Chain Packaging, Textiles, Electronics and Others), and Regional Forecast, 2020-2027.”, mentions that the market stood at USD 1,157.6 million in 2019 and is likely to exhibit an impressive CAGR...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.